Does IXEKIZUMAB Cause Nephrolithiasis? 100 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Nephrolithiasis have been filed in association with IXEKIZUMAB (TALTZ). This represents 0.3% of all adverse event reports for IXEKIZUMAB.
100
Reports of Nephrolithiasis with IXEKIZUMAB
0.3%
of all IXEKIZUMAB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Nephrolithiasis From IXEKIZUMAB?
Of the 100 reports, 13 (13.0%) required hospitalization.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which IXEKIZUMAB Alternatives Have Lower Nephrolithiasis Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID